HK Stock MarketDetailed Quotes
00399 INNOVATIVE PHAR
- 0.184
- -0.008-4.17%
Trading Dec 11 15:55 CST
335.29MMarket Cap30.67P/E (TTM)
0.190High0.184Low1.41MVolume0.186Open0.192Pre Close260.95KTurnover0.08%Turnover Ratio3.23P/E (Static)1.82BShares0.29052wk High-0.73P/B335.29MFloat Cap0.18152wk Low--Dividend TTM1.82BShs Float94.348Historical High--Dividend LFY3.13%Amplitude0.112Historical Low0.185Avg Price5000Lot Size--Div YieldTTM--Div Yield LFY
About INNOVATIVE PHAR Company
Pilot Pharmaceutical & Biotechnology Co., Ltd. (“Formerly United Gene Technology Group Limited”) is a limited company incorporated in the Cayman Islands and surviving in Bermuda. Pioneer Pharmaceuticals and Biotech's shares are listed on the main edition of The Stock Exchange of Hong Kong Limited. Pioneer Pharmaceuticals and Biotechnology is engaged in three core businesses, distributing genetic testing services, distributing biological industry products, and providing health management services.
Company Profile
Symbol00399
Company NameINNOVATIVE PHAR
ISINBMG4783W1073
Listing DateAug 23, 2000
Issue Price1.00
Shares Offered80.00M share(s)
Registered AddressBermuda
Chairmannian jiang
Secretaryhanyan pan
Company CategoryOther
Registered OfficeClarendon House, 2 Church Street, Hamilton HM 11, Bermuda
Head Office and Principal Place of BusinessRoom 2002, 20th floor, Ankang Commercial Building, 145 Hennessy Road, Wan Chai, Hong Kong
Fiscal Year Ends03-31
Employees20
MarketHong Kong motherboard
Phone(852) 2598 6818
Fax(852) 2598 6628
Emailinfo@ipb.asia
Business Pilot Pharmaceutical & Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in the pharmaceutical and biotechnology business. The company operates through five major divisions. The Genetic Testing Services Division provides genetic testing services in mainland China and Hong Kong, China. The Bio-Industry Products Division distributes bio-industry products in mainland China. The Beauty Equipment and Products Trading Division trades in beauty equipment and products in Hong Kong, China. The Securities Investment Division invests in securities in Hong Kong, China and outside Hong Kong, China. The R&D division is engaged in the development and commercialization of oral insulin products.
Company Executives
- Name
- Position
- Salary
- yuanxing gao
- Executive Director, Authorized Representative
- 1.36M
- rong tang
- Executive Director
- 548.00K
- deyao zheng
- Executive Director
- 90.00K
- nian jiang
- Presidencies, Non-executive Directors, Chairman of the Nomination Committee, Remuneration Committee Members
- 60.00K
- yan xiao
- Non-executive Directors
- 60.00K
- yanmin wu
- Non-executive Directors
- 60.00K
- weijun chen
- Independent Non-Executive Director, Chairman of the Audit Committee
- 80.00K
- rongliang wang
- Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
- 60.00K
- jinzhong chen
- Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
- 60.00K
- hanyan pan
- Co-Chief Financial Officer, Authorized Representative, Company Secretary
- --
- yumin mao
- Honorary Chairman, Chief Scientific Advisor
- --
Heat List
HK
Overall
Symbol
Price
% Chg
No Data